Health
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study – DocWire News
J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.ABSTRACTPURPOSE: The immunogenicity and…
J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.
ABSTRACT
PURPOSE: The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer are poorly understood.
METHODS: We performed a prospective cohort…
Continue Reading
-
Business24 hours agoThese ASX 200 shares could rise 50% to 60%
-
General24 hours agoAustralia’s Myanmar community mourns earthquake losses
-
Noosa News20 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News23 hours agoAustralian growers expect to benefit from US tariffs as Trump’s trade war angers markets